EW – Edwards Lifesciences Corporation
Float Short %
1.41
Margin Of Safety %
-6
Put/Call OI Ratio
1.87
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
0.35
Price
79.8
Target Price
96.93
Analyst Recom
1.77
Performance Q
-5.07
Upside
-49.0%
Beta
0.94
Ticker: EW
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | EW | 83.64 | 2.05 | 1.29 | 58201 |
| 2026-01-26 | EW | 84.29 | 2.04 | 2.60 | 58828 |
| 2026-01-27 | EW | 83.58 | 2.05 | 0.08 | 59883 |
| 2026-01-28 | EW | 81.84 | 2.00 | 0.49 | 60450 |
| 2026-01-29 | EW | 81.49 | 1.99 | 1.12 | 60544 |
| 2026-01-30 | EW | 81.37 | 1.99 | 7.38 | 60582 |
| 2026-02-02 | EW | 82.64 | 2.00 | 1.60 | 60780 |
| 2026-02-04 | EW | 79.72 | 2.03 | 3.40 | 61640 |
| 2026-02-05 | EW | 78.08 | 1.92 | 4.78 | 60886 |
| 2026-02-06 | EW | 78.68 | 2.15 | 2.18 | 68268 |
| 2026-02-09 | EW | 76.77 | 2.07 | 9.77 | 66782 |
| 2026-02-10 | EW | 77.04 | 2.18 | 1.39 | 69400 |
| 2026-02-11 | EW | 79.33 | 2.01 | 0.19 | 79394 |
| 2026-02-12 | EW | 76.41 | 2.01 | 0.08 | 79704 |
| 2026-02-13 | EW | 75.84 | 1.92 | 0.71 | 77985 |
| 2026-02-18 | EW | 78.98 | 1.87 | 0.16 | 78693 |
| 2026-02-19 | EW | 78.93 | 1.87 | 0.47 | 78808 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | EW | 83.65 | 5.0 | 71.2 | 2.58 |
| 2026-01-26 | EW | 84.27 | 5.0 | 103.0 | 2.58 |
| 2026-01-27 | EW | 83.59 | 5.0 | 73.5 | 2.58 |
| 2026-01-28 | EW | 81.86 | 5.0 | 48.9 | 2.58 |
| 2026-01-29 | EW | 81.46 | 5.0 | 79.7 | 2.58 |
| 2026-01-30 | EW | 81.36 | 5.0 | 85.9 | 2.58 |
| 2026-02-02 | EW | 82.66 | 5.0 | 119.8 | 2.58 |
| 2026-02-03 | EW | 82.11 | 5.0 | 76.4 | 2.58 |
| 2026-02-04 | EW | 79.75 | 4.9 | 34.1 | 2.58 |
| 2026-02-05 | EW | 78.08 | 4.9 | 48.3 | 2.58 |
| 2026-02-06 | EW | 78.68 | 4.9 | 103.3 | 2.58 |
| 2026-02-09 | EW | 76.76 | 4.9 | 41.4 | 2.58 |
| 2026-02-10 | EW | 77.07 | 4.9 | 95.8 | 2.58 |
| 2026-02-12 | EW | 76.40 | 4.9 | 17.8 | 2.58 |
| 2026-02-18 | EW | 78.97 | 13.4 | 101.8 | 2.95 |
| 2026-02-19 | EW | 78.92 | 13.4 | 87.4 | 2.95 |
| 2026-02-20 | EW | 79.80 | 13.4 | - | 2.95 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | EW | -1.29 | -0.18 | 1.25 |
| 2026-01-26 | EW | -1.29 | -0.08 | 1.25 |
| 2026-01-27 | EW | -1.29 | -0.08 | 1.25 |
| 2026-01-28 | EW | -1.29 | -0.08 | 1.38 |
| 2026-01-29 | EW | -1.24 | -0.08 | 1.38 |
| 2026-01-30 | EW | -1.24 | -0.08 | 1.38 |
| 2026-02-02 | EW | -1.24 | -0.30 | 1.38 |
| 2026-02-03 | EW | -1.24 | -0.30 | 1.38 |
| 2026-02-04 | EW | -1.24 | -0.30 | 1.38 |
| 2026-02-05 | EW | -1.24 | -0.30 | 1.38 |
| 2026-02-06 | EW | -1.24 | -0.30 | 1.38 |
| 2026-02-09 | EW | -1.24 | -1.62 | 1.38 |
| 2026-02-10 | EW | -1.24 | -1.62 | 1.38 |
| 2026-02-11 | EW | -1.24 | -1.62 | 1.41 |
| 2026-02-12 | EW | -1.24 | -1.62 | 1.41 |
| 2026-02-13 | EW | -1.24 | -1.62 | 1.41 |
| 2026-02-17 | EW | -1.51 | -0.47 | 1.41 |
| 2026-02-18 | EW | -1.51 | -0.47 | 1.41 |
| 2026-02-19 | EW | -1.41 | -0.47 | 1.41 |
| 2026-02-20 | EW | -1.41 | -0.47 | 1.41 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
0.73
Avg. EPS Est. Next Quarter
0.75
Insider Transactions
-1.41
Institutional Transactions
-0.47
Beta
0.94
Average Sales Estimate Current Quarter
1594
Average Sales Estimate Next Quarter
1682
Fair Value
75.14
Quality Score
81
Growth Score
89
Sentiment Score
96
Actual DrawDown %
39.4
Max Drawdown 5-Year %
-54.3
Target Price
96.93
P/E
43.06
Forward P/E
24.05
PEG
1.8
P/S
7.63
P/B
4.54
P/Free Cash Flow
57.57
EPS
1.85
Average EPS Est. Cur. Y
2.95
EPS Next Y. (Est.)
3.3
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
17.92
Relative Volume
1.23
Return on Equity vs Sector %
-15.6
Return on Equity vs Industry %
-4.3
EPS 1 7Days Diff
EPS 1 30Days Diff
0.07
EBIT Estimation
Edwards Lifesciences CorporatioSector: Healthcare
Industry: Medical Devices
Employees:
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
stock quote shares EW – Edwards Lifesciences Corporation Stock Price stock today
news today EW – Edwards Lifesciences Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch EW – Edwards Lifesciences Corporation yahoo finance google finance
stock history EW – Edwards Lifesciences Corporation invest stock market
stock prices EW premarket after hours
ticker EW fair value insiders trading